IMDX
Insight Molecular Diagnostics Inc.Company with tickers: IMDX
Market Cap
$180.50M
Shares Outstanding
32,290,167
CIK
1642380
CUSIP
68235C206
13F Activity (30d)
2 filings
1 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Louis E. Silverman | director | Appointed | 2026-06-17 |
| Andrew J. Last | director | Appointed | 2026-06-17 |
| Andrew Arno | director | Appointed | 2026-06-17 |
| Joshua Riggs | director | Appointed | 2026-06-17 |